Session » (1914–1935) Health Services Research Poster III

Date: Tuesday, October 28, 2025

Time: 10:30AM-12:30PM

Meeting: ACR Convergence 2025

10:30AM-12:30PM: Abstract Number: 1923

A Real-World Survey On Physicians’ Perspectives Of Uncontrolled Gout And Gout Management Practices.

10:30AM-12:30PM: Abstract Number: 1916

Adherence to cervical cancer screening programs in women with Systemic Lupus Erythematosus

10:30AM-12:30PM: Abstract Number: 1934

Analysis of the Determinants of Vaccine Acceptance and Hesitancy in Germany: A Mixed-Methods Approach Incorporating Health Insurance Data and Qualitative Interviews with Patients and Physicians

10:30AM-12:30PM: Abstract Number: 1925

Associations between Representation and Quality in Clinical Trials for Systemic Lupus Erythematosus

10:30AM-12:30PM: Abstract Number: 1930

Can a Multinational Awareness Campaign Improve Referral Rates and Reduce Diagnostic Delays in Patients with Chronic Inflammatory Rheumatic Diseases? The Impact of a Prospective Interventional Study

10:30AM-12:30PM: Abstract Number: 1917

Characterizing the Frequency and Timing of Changes in Patient-Reported Social Risk Factors among Rheumatology Outpatients

10:30AM-12:30PM: Abstract Number: 1931

COSMOS Prevalence of aTTP in SLE

10:30AM-12:30PM: Abstract Number: 1927

Development of the PREVAIL model of care: Optimizing feasibility and acceptability for trial implementation

10:30AM-12:30PM: Abstract Number: 1929

Economic Burden of Macrophage Activation Syndrome (MAS) in Patients with Still’s Disease (Systemic Juvenile Idiopathic Arthritis (sJIA) and Adult-onset Still’s Disease (AOSD)): Analysis of a US National Administrative Claims Database

10:30AM-12:30PM: Abstract Number: 1932

Evaluating a Potential Cause of Excess Lung Cancer Mortality in RA: An Analysis of Chest CT Imaging Frequency in RA

10:30AM-12:30PM: Abstract Number: 1922

Exploration of patient and clinician perspectives on rehabilitation in contemporary rheumatology care for rheumatoid arthritis: A qualitative study

10:30AM-12:30PM: Abstract Number: 1919

Financial insecurity and discrimination are associated with patient-reported quality of life in patients with SLE

10:30AM-12:30PM: Abstract Number: 1915

Innovative Clinical Trial Recruitment Approaches in Lupus Research: LuCIN Site Perspectives on Use of Social Media and Artificial Intelligence

10:30AM-12:30PM: Abstract Number: 1920

Lung Cancer Screening with Rheumatoid Arthritis: A Retrospective Claims Analysis

10:30AM-12:30PM: Abstract Number: 1928

Oral Health in Patients with Rheumatic Diseases: A Pilot Quality Improvement Program

10:30AM-12:30PM: Abstract Number: 1914

Performance Comparison of Artificial Intelligence tools ChatGPT, Bing AI, and Google Bard for Clinical Rheumatology Decision Support: When AI Talks Rheumatology

10:30AM-12:30PM: Abstract Number: 1921

Re-escalation of Treatment in Older Adults with Rheumatoid Arthritis After Anti-TNF Therapy De-escalation

10:30AM-12:30PM: Abstract Number: 1926

Real World Rate of Efficacy of Adalimumab Biosimilars Following a Mandated Switch in an Academic Medical Center

10:30AM-12:30PM: Abstract Number: 1924

Real-World Treatment Patterns of Patients with Systemic Autoimmune Rheumatic Disease-associated Interstitial Lung Disease After Progression in The United States

10:30AM-12:30PM: Abstract Number: 1935

Sex-associated disparities in industry payments to US authors in high-impact rheumatology journals correlate with author impact

10:30AM-12:30PM: Abstract Number: 1933

Specialist Wound Care Services Provision and Sharp Debridement Practices for Digital Ulcers (DU) Management in Systemic Sclerosis (SSc): An International Survey

10:30AM-12:30PM: Abstract Number: 1918

Vigorous Physical Activity in Patients with SLE Was Not Associated with Disease Activity or Socioeconomic and Social Factors

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].